295 related articles for article (PubMed ID: 26638758)
21. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.
Kanamori H; Takemura G; Goto K; Tsujimoto A; Ogino A; Takeyama T; Kawaguchi T; Watanabe T; Morishita K; Kawasaki M; Mikami A; Fujiwara T; Fujiwara H; Seishima M; Minatoguchi S
Am J Pathol; 2013 Mar; 182(3):701-13. PubMed ID: 23274061
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism.
Sung MM; Das SK; Levasseur J; Byrne NJ; Fung D; Kim TT; Masson G; Boisvenue J; Soltys CL; Oudit GY; Dyck JR
Circ Heart Fail; 2015 Jan; 8(1):128-37. PubMed ID: 25394648
[TBL] [Abstract][Full Text] [Related]
23. Iron-overload cardiomyopathy: evidence for a free radical--mediated mechanism of injury and dysfunction in a murine model.
Bartfay WJ; Bartfay E
Biol Res Nurs; 2000 Jul; 2(1):49-59. PubMed ID: 11232511
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol Ameliorates Contrast Induced Nephropathy Through the Activation of SIRT1-PGC-1α-Foxo1 Signaling in Mice.
Hong YA; Bae SY; Ahn SY; Kim J; Kwon YJ; Jung WY; Ko GJ
Kidney Blood Press Res; 2017; 42(4):641-653. PubMed ID: 29035878
[TBL] [Abstract][Full Text] [Related]
25. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
Preziosi ME; Singh S; Valore EV; Jung G; Popovic B; Poddar M; Nagarajan S; Ganz T; Monga SP
J Hepatol; 2017 Aug; 67(2):360-369. PubMed ID: 28341391
[TBL] [Abstract][Full Text] [Related]
26. Adiponectin ameliorates iron-overload cardiomyopathy through the PPARα-PGC-1-dependent signaling pathway.
Lin H; Lian WS; Chen HH; Lai PF; Cheng CF
Mol Pharmacol; 2013 Aug; 84(2):275-85. PubMed ID: 23723143
[TBL] [Abstract][Full Text] [Related]
27. Iron and oxidative stress in cardiomyopathy in thalassemia.
Berdoukas V; Coates TD; Cabantchik ZI
Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
[TBL] [Abstract][Full Text] [Related]
28. Cardiac complications in beta-thalassemia: From mice to men.
Kumfu S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Exp Biol Med (Maywood); 2017 Jun; 242(11):1126-1135. PubMed ID: 28485683
[TBL] [Abstract][Full Text] [Related]
29. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model.
Oudit GY; Trivieri MG; Khaper N; Husain T; Wilson GJ; Liu P; Sole MJ; Backx PH
Circulation; 2004 Apr; 109(15):1877-85. PubMed ID: 15037530
[TBL] [Abstract][Full Text] [Related]
30. Establishment of secondary iron overloaded mouse model: evaluation of cardiac function and analysis according to iron concentration.
Moon SN; Han JW; Hwang HS; Kim MJ; Lee SJ; Lee JY; Oh CK; Jeong DC
Pediatr Cardiol; 2011 Oct; 32(7):947-52. PubMed ID: 21656238
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy.
Ahmad I; Hoda M
Pharmacol Res; 2020 Nov; 161():105112. PubMed ID: 32758636
[TBL] [Abstract][Full Text] [Related]
32. Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.
Gordan R; Wongjaikam S; Gwathmey JK; Chattipakorn N; Chattipakorn SC; Xie LH
Heart Fail Rev; 2018 Sep; 23(5):801-816. PubMed ID: 29675595
[TBL] [Abstract][Full Text] [Related]
33. QKI deficiency promotes FoxO1 mediated nitrosative stress and endoplasmic reticulum stress contributing to increased vulnerability to ischemic injury in diabetic heart.
Guo W; Jiang T; Lian C; Wang H; Zheng Q; Ma H
J Mol Cell Cardiol; 2014 Oct; 75():131-40. PubMed ID: 25068621
[TBL] [Abstract][Full Text] [Related]
34. Effects of long-term resveratrol-induced SIRT1 activation on insulin and apoptotic signalling in aged skeletal muscle.
Sin TK; Yu AP; Yung BY; Yip SP; Chan LW; Wong CS; Rudd JA; Siu PM
Acta Diabetol; 2015 Dec; 52(6):1063-75. PubMed ID: 25959421
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein.
Kuno A; Hori YS; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
J Biol Chem; 2013 Feb; 288(8):5963-72. PubMed ID: 23297412
[TBL] [Abstract][Full Text] [Related]
36. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
[TBL] [Abstract][Full Text] [Related]
37. Melatonin therapy for diabetic cardiomyopathy: A mechanism involving Syk-mitochondrial complex I-SERCA pathway.
Zhou H; Yue Y; Wang J; Ma Q; Chen Y
Cell Signal; 2018 Jul; 47():88-100. PubMed ID: 29601906
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
Gu XS; Wang ZB; Ye Z; Lei JP; Li L; Su DF; Zheng X
Genet Mol Res; 2014 Jan; 13(1):323-35. PubMed ID: 24535859
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation.
Hu YX; Cui H; Fan L; Pan XJ; Wu JH; Shi SZ; Cui SY; Wei ZM; Liu L
Can J Physiol Pharmacol; 2013 Dec; 91(12):1044-54. PubMed ID: 24289075
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol Ameliorates Pressure Overload-induced Cardiac Dysfunction and Attenuates Autophagy in Rats.
Wang L; Gao M; Chen J; Yang Z; Sun J; Wang Z; Huang X; Yuan T; Shen X; Xian S
J Cardiovasc Pharmacol; 2015 Oct; 66(4):376-82. PubMed ID: 26167810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]